Florida H0567 regulates stem cell therapy in podiatric medicine, requiring informed consent and facility accreditation.
Florida H0567 amends podiatric medicine regulations to include provisions for stem cell therapy. It mandates that podiatric physicians obtain signed consent forms from patients before performing stem cell therapy, detailing the treatment's nature, risks, and alternatives. The bill prohibits therapies involving cells derived from aborted fetuses and mandates that stem cells used in therapy come from FDA-registered facilities or accredited entities. It also requires podiatric physicians to notify patients about unapproved therapies and their potential risks.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.